Casey Means: We’ll get started soon. David Flinner: You’re muted, Josh. Josh Clemente: Zoom muted me classic. All right, so starting off with the recent achievements for the week. Firstly, the version two of the charts are in the internal app. So I was playing around with this morning. We’ve talked a little bit about it on this meeting and obviously in Slack discussions, but I’m going to leave this to David and probably Alan to describe in more detail, but these are the foundation for powerful visuals both now and then in the future. So being able to renovate the way that charts are rendered and interacted with is, it’s a mechanism, it’s tool set that we can use well into the future. And I’m really excited for it. It’s beautiful. I appreciate everyone’s work on it so far. It’s quite a surprise that we were able to get such an improvement, I don’t think we expected to. Josh Clemente: Next up testing Basecamp. Josh Clemente: So we have a lot of internal tools right now. Some of us, myself most specifically, get tool fatigue occasionally. So we’re trying out Basecamp as a central work hub to consolidate sort of email and Slack discussions into a single work stream or a workflow. And then we’ll likely bolster that with tools like Notion for some of their deeper work capabilities. But just something to put on the radar for those of you that are already interacting in Basecamp, definitely keep track of your experience, and it’s really important for us to understand whether this is value additive or value subtractive. So far I’m feeling optimistic about it. And thank you Miz for spearheading that. Josh Clemente: Version one of our culture documentation initiatives. Josh Clemente: So we’re a young company we’re growing quickly, and it’s really important that we continue to foster the amazing culture that we’ve got going on. And so part of that was just organic sort of interviews from parts of the team. And I really appreciate everyone that participated in this, it was super insightful for me and we’re definitely going to iterate on this project and keep it going. So appreciate you guys jumping in doing that. It was quite vulnerable I’m sure, but the end result I think is going to be very informative for how we continue to onboard people and help them to understand who and what Levels is. Josh Clemente: And then proceeding with Whoop and Levels case study, we’ve been kind of doing this in the background for some time now, but we’re going to get 20 or 30 Whoop and Levels employees running this case study. And we’ll be comparing the sort of metabolic insights with the recovery insights, so that we can see whether or not there’s anything there and then we’re going to discuss it on the Whoop podcast shortly thereafter. And then we’re also going to be launching several small pilots with Equinox, both on members and their trainers, sort of cadre called I think, Tier X. So more to come on that. Josh Clemente: And then things have been progressing quickly on our interaction with Truepill and their physician network study MD, and they also use other physicians. But essentially, we’re consolidating the consultation system into the Truepill system. And this is going to make it much easier on us for both single thread communications, and also scalability. So the individual practitioner arrangements are being sunsetted now, can’t express enough appreciation for them working with us as we were sort of scaling the platform upon which they could take consults. And now it’s just the right time for scaling to move this into the consolidated system going forward. Josh Clemente: Lab tests V1 kits have arrived, you can kind of see the first version, the hormones system from ZRT, which I received in the mail, I think yesterday. So we’re going to start getting additional analytes and this is very much early stages, but this is going to be the foundation for supplemental testing in the future. JM is also pushing ahead with scheduling in in-home phlebotomy, which would unlock additional testing, things like potentially oral glucose tolerance tests, NMR lipid panels, the really deep insightful analytes that will provide context and calibration for just the CGM data that we’re gathering. Josh Clemente: And then lastly, we’ve got a couple ongoing community initiatives levels ambassadors. So this is a core group of members who have opted in to continually provide us with feedback directly. We’re also spinning up Swag 2.0, which you can see right here, we’ve got a backpack, we’ve got a beanie and we’ve got some drink canisters there. So just continuing to push ahead with the community stuff and getting some great feedback from at least our die hards. Josh Clemente: Other great things that happened this week, Will Smith, who is currently going through a superhero transformation, is interested working with Levels. More to come on that. We’ve got some really exciting, I think evidence, that people are paying attention to our content. Kelly LeVeque and Casey did a great IG live, which I really enjoyed. I was only able to catch part of it, but as good as usual, 6,300 views in like 24 hours. Another video from user-generated content on TikTok, got like 270,000 views in 24 hours. So a lot of interesting stuff, people are very intrigued by, I think the placement, and the uniqueness of the wearable that we’ve got. Josh Clemente: And then lastly, I just want to highlight the Truepill onsite. So JM and Miz were able to go on site and check out Truepill’s operations, and it was really actually quite striking to just see these simple images of the pre-stage boxes and Levels kits. David summed it up nicely, where he said he remembers the first Truepill tour, where we saw everyone else’s company boxes and wondered if we’d ever get there ourselves. And that’s exactly how I felt, and it’s just amazing to see. This is one of two warehouses where levels kits are being shipped out, it’s just wild. Josh Clemente: Sorry, the wind is crazy here and my doors are slamming behind me. So I have to go lock this. Cool. All right, we will jump ahead from there. Josh Clemente: Casey, I’m going to hand this off to you, but very excited for this intro. Casey Means: Great. I could not be more thrilled to introduce Dr. Robert Lustig and welcome him as a Levels advisor. So just a quick intro, Dr. Lustig is a neuro endocrinologist and professor emeritus of pediatrics in endocrinology at UCSF. He trained at MIT for undergrad, Cornell medical school, did a master’s of law from UC Hastings, and his fellowship at UCSF. And many of you know him I know, as the author of several groundbreaking books focused on metabolic health, processed food, sugar, and the human response to addictive substances. And most recently this month, he published Metabolical; The Lures And The Lies of Processed Food, Nutrition And Modern Medicine. And it is hard to put into words how riveting, and compelling, and rational this book is. And it is really, it’s a must read for our team, and in my opinion, should be for all doctors, investors, parents, teachers, and politicians. Casey Means: It’s basically a manifesto of why we are here doing what we’re doing. Dr. Lustig is a truth teller. He has vocally and clearly exposed the public to the systems factors that have led to our metabolic health crisis, and so much of human suffering, and has done also immense basic science research on the physiology of these processes. And on our advisory board, he’ll be collaborating with us on strategy content and co-amplifying the message of metabolic health. So we are so excited to welcome you Dr. Lustig, and thank you so much for being here this morning. I’ll turn it over to you. Dr. Robert Lustig: Well, Casey, thank you, but I don’t know who you were talking about. Well, appreciate it. Dr. Robert Lustig: So, first of all, I am here really because of the enthusiasm of Casey Means. You know, the fact that she was an ear, nose and throat physician and now does this, speaks to her open-mindedness and her understanding of what went wrong, and the fact that she had to retool and in the pro process retool everyone else. And that was extraordinarily inspiring. I feel the same way, I was in the ivory tower system for 40 years and for the first 20, I was just basically scraping my way up the ladder. And as I did more and more research, I came to the realization that, what we were telling patients was wrong. It was just wrong. Dr. Robert Lustig: And it wasn’t just my anecdotal evidence that said it was wrong, it was actually the science and some of the science was science that I developed and others. And so I came to a, shall we say come to Jesus moment somewhere along the way, and realized I needed to do something different in terms of both my patients, and in terms of what I was promulgating. And that didn’t earn me any friends. On the other hand, the science is my sword and my shield, and I’ve been sort of, as Casey said, truth telling ever since. We continue to do research, I’m actually starting a study very soon on metabolic psychiatry, whether or not diet can affect bipolar and major depressive disorder, and whether or not it’s because of mitochondrial function in the brain. We’ll be using P-31 magnetic resonance spectroscopy to try to assess ATP generation within the brain on different diets. Dr. Robert Lustig: So I’m keeping my hand in, I’m keeping close to the science. And the point is that, after 40 years of science and 40 years of clinical practice, I have some expertise to be able to lend to the work that you’re doing. I believe in personalized nutrition, I believe in personalized health. What I don’t believe in, is what we currently have right now. We need to basically up our game, and we have several more analytes that have to go into the mix Other than just glucose. You are getting some of them, I just heard about your blood kit. The question is, can some of these be done in real time in different channels, other than glucose. And I’m working with developers on that, with the idea that ultimately people should know what their food does to them. And when they know that, that hopefully will be a primary driver of change. Dr. Robert Lustig: Obviously, the change has to occur at many levels. It has to occur at the patient level. It has to occur at the doctor level, which is why I wrote the book. I actually wrote the book for doctors. I actually hope this book will become a medical school textbook. It’s got 1054 references, almost all of them to the primary literature on purpose for that reason. And ultimately, it has to affect the food industry and politicians, in order to be able to actually level the playing field. So I’m in it. I’m in it to fix the problem any way I can, and I see levels as a way of doing that. I have other ways of doing that, that I’m also involved in, one of which you may hear about shortly. Dr. Robert Lustig: Casey knows about it. It’s actually a proprietary fiber, which turns apple juice in the intestine back into apples in order to reduce the glycemic excursion, reduce the tsunami of sugar hitting the liver reducing the liver fat, therefore reducing the insulin resistance, therefore improving metabolic of health. And Casey, just so you know, we just got our first major investor yesterday. So that clinical trial will go on, and I will probably be approaching this board with this information sometime in the future, as to whether or not Levels would be a good place for that trial. But we’re not up to that today. The point is I’m here to be of help, I’m here to be a resource, I’m here to be able to lend my expertise to try to move the ball forward, to try to improve everyone’s metabolic health. Happy to take any questions. Casey Means: Thank you so much for that awesome introduction Dr. Lustig, and I think two lines that are going to stick with me are research is my shield and my sword, and just needing to stay close to the science. I think those are powerful statements. And certainly, from my perspective, I will do anything in my power to get this book into my former medical school. So I think that I agree with you. I think exposing people to what’s in metabolical early on in their career, could have profound implications for how people shape their careers and practice medicine. Dr. Robert Lustig: You know, you have to realize that only 28% of medical schools even have a nutrition curriculum. Casey Means: And when they do, it’s like less than 20 hours, usually. Dr. Robert Lustig: Exactly. A median of 19.6 hours of exposure, considering that a standard medical school curriculum is 2,000 hours of exposure. 19.6, basically it’s 0.1% of the time is spent on nutrition, except that nutrition could solve 75% of the problems. So it’s clearly lopsided. And the reason is because, big pharma controls the medical school curriculum, and they don’t want to know about nutrition. The problem is that, virtually all chronic diseases that we currently are seeing, witnessing the increase in incidence, and prevalence, and severity, they are not druggable, but they are foodable. So we could fix it with food, but doctors don’t know that. Josh Clemente: Oh, this is a series of steps in that direct, so thank you, Dr. Lustig, and very excited to hear about your work on exposing continuous analytes beyond glucose as well. Obviously, we’ll be very interested in digging into that with you. There’s a ton of potential, and basically step one is demonstrating that people care enough about this to wear something that’s measuring molecules in their body, and to act on it. So thank you for joining us and excited for many more deep conversations to come. Josh Clemente: Okay, jumping ahead Quick culture and kudo slide. So this one, this week we had some great stuff going on. I want to highlight two different sort of segments of feedback, but firstly, the content shutout. So Haney, Casey, got to hand some credit over this. So we had some questions, some tension around questions about accessibility, about price point, about whether or not Levels cares about metabolic health for everyone or just for a specific group. Josh Clemente: And the content that Casey and Haney have already to walk through the specifics on why Levels mission statement applies to everyone, and how we see the trajectory of this development, was perfect. And as you can see in this response from the CEO of Whole 30, “These articles have more than met my exceedingly high expectations as to how Levels would address these questions with their community. It’s exactly what I hope to see. You brought even more positive talking points like consumer demand driving down the price of all CGMs.” Josh Clemente: This is why the content program exists. It’s essentially to scale the responses to the important questions and help people understand. And so just a huge shout out to the team over there, doing everything to inform our audience. This is a really great example. Josh Clemente: And then on the member insight side, twice this week we had big brands who are very well known, reach out to our team and say, “Hey, can you guide us on how to get insights from our members, and how to use them effectively inside our organization? You guys are doing this so well, and we just would love to learn more about what your system is.” And so that’s twice in a week, pretty awesome. Have to give the shout out to everyone involved in touch points with members. This is all stacking up into a perception, not just to the customer, but also to organizations who are watching us and looking at us now as an example for their organizations. And that is really hard to do. So Mike and the entire ops team, really appreciate what you all are doing. It’s huge. Josh Clemente: All right, over to David. David Flinner: All right. Josh alluded to the charts V -2, and what you have here on the right hand side is the in-app version of the new charts. And I wanted to briefly call out why this is so important. So as Josh mentioned, this is sort of an unexpected gift that we had, in a quick experiment we found out that we actually could swap out our old charting library for a new one. And this is important because, it gives us huge flexibility on designing new experiences. The old chart library was very rigid and we could only view a very limited number of things with it. In the new library, we can now kind of design any sort of experience we want, and that’s within the realm of feasibility for us to have. So if we wanted to call out a specific behavior change or a really interesting way to visualize how exercise affects your glucose response, we could now do that visually. It still takes work, but it’s within the realm of possibility. David Flinner: And then the speed is a huge, huge material win. Just speed is a feature you can think about like, Google search results being fast. Many of us are not Android users, but if you have been using it on Android, Levels was almost barely usable in some states, and these graph improvements are going to make it so that it’s almost on par with iOS performance. So really opening up the spectrum of users, and this will get really important when we launch. And with our accessibility goals, there are way more Android users in the world than iOS users. So this really opens up Levels to being able to reach more people. And then just a high bar for beauty. Because this is a flexible canvas, we can now start to focus on the finer details on things that matter, and highlight things that will close the loop on these feedback systems in subtle ways. David Flinner: If you look at the GIF on the right, you’ll see that when I’m tapping through the different entry icons right here between walking and the food. The circle kind of subtly highlights itself, and kind of goes bigger and smaller. And it’s a subtle affordance that will draw the user’s attention to, “Hey, this happened right when the spike started, closing the loop on my choice caused that blood sugar rise,” and helping you think twice about it. So these are the small steps we’re taking, but like Josh said, the future’s bright here. Next slide. David Flinner: And John has been and working and pairing closely with Alan on the redesigned add log flow. Some of the cool things that we’re experimenting with this, are a better version of the copying past log. So surfacing frequently log meals in a dynamic manner when you click that add log button. So if it’s in the morning, potentially you’ll see, “Hey, here’s your frequent breakfast, afternoon, maybe frequent snacks, whatever.” And then we’re also testing out a new version of auto complete instead of copy past logs. So part of this is refinement, part of it is experimenting with new models on getting people to log faster, and we’ll see how that works. Next slide. David Flinner: Maria’s been working with Alan on adjusting the zone review page, and this is the scores and the badging. And there’s been a lot of thoughtful intentionality around how we can tweak the colors, tweak the scores and the layout, to provide value for people to understand what their scores mean, and index on it in the appropriate manner. So that’s ongoing. Next slide. David Flinner: And then into a few of the experiments. I’ll be previewing some of the stuff that we’re kind of conceptually working on right now, not necessarily in engineering, but one of these is the nutritionist pilot V2. And what’s cool about this one is, we learned that members do indeed appreciate nutritionist insights if they have access to that. We wanted to run another iteration of it, learning a bit deeper value, a bit deeper about what people will actually prefer about the nutritionist experience. But then also tying it towards one of the future hypotheses we have as a company, which is the marketplace model and membership model. David Flinner: So JM and Sam are playing with an MVP implementation, where we can list these third-party vetted nutritionist in a marketplace manner, sort of as as a dipping our toes into marketplace, dipping our toes into, can we add extra value to our members if we were to pivot to a membership model? This is just work in progress. And if you have thoughts, feel free to jump in and comment on the in progress spec. Next slide. David Flinner: Another cool experiment that I’m working on right now, is what I’m calling Dr. Casey’s data. And this is an MVP for what we’ve been… some of us have been talking about, which is another concept on Twitch for metabolism. Which is essentially, Levels has this ambition of being the… essentially connecting everyone in the world who cares about this sort of information, and letting… Like Levels will give you great automatic insights, but we’ll also connect you with each other so that if you don’t know the right answer, you can find people who are like you who are also vegan, who are also, I don’t know, certain dietary philosophies. You can engage with them. You can learn from them. And the idea behind Dr Casey’s data is, what if there was a way that, if you opt in, you could expose your profile to other people so that instead of people learning on their own, they could just go learn through osmosis. David Flinner: They could say, “Hey, Casey’s always posting on her Instagram about the foods that work for her, but I don’t think I could source myself, what is she doing that’s so good for her?” And they could just load her profile and see what she does in her catalog. Maybe this person’s at Chipotle and they’re like, “Hey, what does Casey get when she goes to Chipotle?” So they type in Chipotle in Casey’s catalog and they see, “Oh, here’s Casey’s stuff that works for her. Let me try that next time.” David Flinner: So something that I’m still thinking through, it’s not in development yet, but I think that has some promise to start testing the hypotheses around community and whether people want that, and not just community, but whether people can actually learn healthier habits through osmosis from other people. Next slide. David Flinner: And then something I’ve been working on the last couple weeks is, based on your feedback from the first round of roadmap visualizations, I’m putting together another concept, it’s almost done and it’s two things. One, is a roadmap visualization, and then the car/engine that we’ll drive to get there. And so what you see here in this slide, is the roadmap visualization just a bird’s eye view on the left, and then a medium fidelity view here on the right. And of course you can’t read it, but I’ll send it out. But the idea here is to give you just kind of the high level arc of where we’re going as a company. And that’s very clear in the near term, what we’re doing now, a little bit fuzzier on what’s next. And then for the future as a startup, we don’t really know where we’re going to be driving yet. We have some hypotheses and we’re going to be testing a lot of things, so it’s very nebulous for the future, but just to give you a gist as to where we think this could go, that’s what that’s for. David Flinner: And then also, all of the experiments that we’re running right now, that will start to clarify and de-cloud the future concepts and see what we’re doing now to try to gain clarity in unlocking those. Next slide. David Flinner: And then more for the product development team, I’ve been putting together a proposal for a lightweight way to just track how we usher raw ideas and what we could be doing all the way through to, towards shaping those and shipping them as customer value. And that’s sort of how I see the product development process at its core. And so if we can come up with an engine that just lets anyone feed in raw ideas, how do we prioritize those ideas and figure out what’s worth working on to experiments, and then getting those through to shipped value and type velocity iteration loops, that can be the engine that takes us on that journey to the roadmap and figuring out where the ultimate value is. So we’ll appreciate all your thoughts on this as well when I send it out, hopefully up today. Next slide. David Flinner: Oh, sorry, this was supposed to be earlier, but still thinking about some of the food stack rank experiments. I think Gabriel started working on that this week, and there’s some overlap with this with what will be talking about a bit later on meal insights. And with that, I’ll kick it to Alan. Alan McLean: So there’s a mix of both down in the weeds and up high stuff here. So I think as we’ve been starting to touch more parts of the experience, we’re starting to get a better at idea of what a design system could be. And what this really is, is just having a toolkit so that we can more quickly iterate and have a consistent look and feel on different screens. We’ve been playing with a lot of greens. There’s even more screens of this sort of mix of different potential palettes, and typographic treatments. So that’s something that it seems subtle, but it’s actually super important for us to have something that looks and feels beautiful and consistent. Alan McLean: David and I have spent a lot of time looking at some of these sort of emerging ideas that have a lot of potential I think. meal analysis is one of them. It’s an opportunity to sort of break down what potentially went wrong in this meal. I think we’re always surprised when we see some of these threads from our members around, “Why did my glucose spike? I didn’t realize that this thing that I thought was healthy, was actually potentially causing a problem for me.” Alan McLean: And so we wanted help our users close the loop a little bit more, and so looking at potentially ways to, sort of identify individual components of a meal, and potentially using glycemic index with some other metric related to glucose response in the community and surfacing that for our members so they can better understand. Alan McLean: And then finally, a lot of time this week was spent sort of down in the weeds on charts and analysis tasks, looking at how we can make it more consistent for some of our power users. Yeah, that’s it for time this week. Josh Clemente: All right. Awesome. Thanks, that was huge. Rapid update, still progressing on our main roles. So inside council, head of research still have software developer roles open, and we have a few others that were kicking around in the background, which we’ll eventually make it onto workable as we start to externalize some of the needs we have. So for those watching outside, if you know people that would be a good fit for any of these, please refer them in. Miz. Michael Mizrahi: Great. So as Josh alluded to in the announcement slide earlier, JM and I had a chance to visit Truepill Brooklyn this week. So as you know, we have two fulfillment centers with Truepill, one is in Brooklyn, one is in Hayward. We are not a pharmacy, we’re not a fulfillment company, we’re not an operations company, we’re a software company. But a big part of our product, is making sure that members have access to CGM. And then once they do, they can then use the Levels software. And so important for us to understand how Truepill is working, and make sure that that relationship with them as a pharmacy and as a physician network is going well. Michael Mizrahi: So the purpose of this was really just to see what they’re doing on the floor itself. As a remote company, easy for us to do a lot of things over Zoom and over Docs, but nothing beats actually going to the floor and seeing how things are working. So there’s a lot of frameworks for this around continuous improvement, lean Sigma, using some of those principles very lightweight, but just paying a visit to the site is basically what we did here. Michael Mizrahi: A few of the things that we had in mind to keep an eye open for that the ops team has been dealing with, delays shipping around weekends. Sometimes we place an order on a Friday for a sensor replacement, and it might take a few days to get to a member into the middle of the following week, we want to understand what’s going on there. We’ve had in the past some quality control issues on packing the kits, wrong number of performance covers, assembled in the wrong order, all these kinds of things. So we want to get a peek into what they’re doing on that front. We have upcoming inventory changes, in the event that we change our inventory and move over to other products. Michael Mizrahi: We need have different packaging, different inventory management. So taking a peek at that. And then some other processes there. So really helpful to see, I’ll have some photos in the next slide we can talk a little bit more about. Michael Mizrahi: Other than that, some other big updates from the ops team this week. We want to give a call out to Jesse for rewriting all of our subscriptions saved reply copy. With the product changes that Jeremy and the team have done, a lot of our processes changed so a lot of our communications around that needs to be updated. So Jesse, thanks for hopping in there and getting that done. Michael Mizrahi: Braden, doing a great job across a bunch of different, been scheduling a lot of calls. We’ve got community calls, feedback call, product calls. So I appreciate you moving all those along. Michael Mizrahi: And then glazed over earlier but important to mention, the in-app learn module now is updated content. So that tab has been a little bit stagnant for some time, but Mercy’s taken it on and totally refreshed. And so together with David and Haney, keeping that up to date. And so if you tap that tab, which you probably haven’t in a while, you’ll have all of our recent content there and a weekly feature article updated moving forward. Really happy to see that in there. Michael Mizrahi: And then next slide, Josh, and I’ll just do a quick refresher. I know we’ve had a lot of folks join lately and recently, and this is really, really basic ,and so not exhaustive. But for those who might not be familiar with the order flow, up top those light green arrows, that’s how an order gets placed. A member places, an order, they fill out the medical consult form which asks a bunch of questions, that then gets passed over to a physician network, increasingly the Truepill physician network, which uses Study MD, and a physician reviews the consult and makes the decision on whether or not to prescribe a CGM for their patient, for our member in that case. Michael Mizrahi: And if a prescription is approved, we can then help fulfill that. So then that gets passed over to Truepill to fill the request. So part one is really the prescription and consult process. Part two is the fill request, the physical packing of the prescription. And so that’s what we have here. And so there’s a few different steps there involved. The Truepill facility is a pharmacy, and so they have farm techs on site, they have pharmacists, they have medications and substances, and they have a lot of regulations they have to follow in order to keep those licenses and stay within bound. Michael Mizrahi: So some of those steps are listed out here and things can go wrong at each of those steps. Orders can get lost, they can get assigned to the wrong facility, and so that’s what we like to keep an eye on and just understand how it works, that when things go wrong, we can intervene. Michael Mizrahi: I think we have a quick question here in Zoom, Dr. Lustig? Dr. Robert Lustig: Yeah. Who are these MDs, and what training do they have, and what criteria do they use to determine who gets what and why? Michael Mizrahi: Yeah, good question. So in the past, we’ve had two networks of physicians, I’ll keep it simple in this case. We partner with Truepill, which partners with a company called Study MD, and it’s a network of telemedicine physicians of a bunch of different, different backgrounds, and they select… The Truepill network and medical team selects, which physicians to put on the Levels account. There is guidance from Truepill on the Levels program explaining what we do, explaining the CGM usage, and explaining the product generally. But the ultimate decision is in that physician’s hands, on whether or not to prescribe or not for the medical consult that they’re reviewing. And so a lot of that is done asynchronously. If they need to follow up with a patient, they’ll make those connections. Dr. Robert Lustig: Well I mean, what’s their training? Are they diabetes physicians or are they just general internists? Michael Mizrahi: Yeah. Dr. Robert Lustig: Do you supply them with any training about how to use Levels? I mean, does everyone get it, or what kind of triage process goes on? Michael Mizrahi: Sure. I- Dr. Robert Lustig: I’m sorry if this is whole news to everyone, I’m trying to learn. Michael Mizrahi: It’s a good question and a good refresher, and Casey can hop in too, to fill me in on some of the blanks or to add details. So a mix of physicians, we’ve seen some internists, we’ve seen some GPS, there’s some specialists mixed in there. These are physicians that have signed up to do telemedicine consults. Truepill does give them guidance on the program and on the prescription. These physicians are not familiar with Levels specifically, and they haven’t used Levels. What they’re generally evaluating is whether or not the patient in this case is, a good candidate for CGM usage to improve their health and wellness. And so they make that decision on the prescription on their own, looking at some of the safety details around the product. Michael Mizrahi: So whether or not someone’s diabetic, whether or not they’re pregnant, have medical implants, allergic to adhesives, they’ll review the medical consult and make a call based their training and guidance. Josh Clemente: Yeah. And given that Levels is not practicing medicine ourselves, that clinical protocol and the procedures is associated, are guided by the clinical directorate over on the Study MD and Truepill side. So the professional corporation they’ve arranged, they flow the information down to the physicians based on safety and effectiveness data for the specific devices. And then also some basic information about the Levels of software. But as Miz mentioned, this is mostly oriented around the CGM device itself, as opposed to Levels, which is a wellness software which is not actually prescription controlled. Dr. Robert Lustig: There are other programs like Blip, who decides whether they go to say Blip or Levels or any other vendor for that matter? Is that within Truepill, or how is that influenced? Josh Clemente: Yeah, so these are specific requests from a patient or a customer of Levels, requesting the Levels program and CGM access. And so the physician is evaluating that request explicitly, as opposed to a more generic request, which would come through maybe other channels into Truepill, which they could then decide whether to recommend Levels or Blip or something else. But since these are coming through the Levels channel, they are specific and they’re therefore sort of almost a binary outcome, which, we don’t have control over. Dr. Robert Lustig: Okay. So it comes in with that in mind to start with, as opposed to something that comes later? Josh Clemente: Exactly. Yeah, and we’ll be looking at ways to sort of expand that reach and maybe be available as a referral option through other channels, but today, since we are still in beta, there are only a few sort of requests that can be requesting Levels via the platform we’ve built. And so yeah, we’d love to work with you on helping you understand more of the mechanisms there, and also the ways that we could potentially expand access as we grow. Josh Clemente: All right. Thank you, Miz for the update. A quick update on financials from Ben. Ben Grynol: 105 weekly recognized revenue, strong week 581 monthly recognized revenue, so best month to date in the history of Levels. 92 in the bank sitting well there, and interesting insight. So last month we were at 574 K of recognized revenue and a 12% refund rate, and we’re sitting at 10%. So 2% Delta is a nice little increase, so great work everyone. Josh Clemente: Thank you, Ben, over to you, Mike. Mike DiDonato: I’m going to try and run through this quick. So just wanted to highlight a consistent theme that we heard, it’s definitely not new, definitely revolves around tags worth mentioning, because it came up on just about every interaction that we had in a few different ways. Highlight a few different examples. One in particular, I think a woman said, “I wish I could make my Levels calendar like in an emotional calendar, because my glucose seems to fluctuate based on how I’m feeling or what’s happening at work.” I think she mentioned like something like smiley face journaling. Mike DiDonato: And then we had another individual that told us, “I’m crushing it with Levels, and then I started traveling and I’d love to be able to tag that, so that I could go at the end of my month or in the end of three months and kind of understand and contextualize that data.” Mike DiDonato: And then the last one to highlight would be around food or like menu tags. This individual was actually like logging lunch as their log, and he is like, “If I could pick and choose my live strong app to add specific ingredients for a given meal, A I would log more and B, it would be more actionable and insightful to me personally.” Mike DiDonato: That’s it. Josh Clemente: Awesome. Thank you. All right, Stacy’s got a special update on creative. Stacy: All right. I just wanted to share some of the beautiful images that we captured during this spring’s series of photo shoots around the U.S. I traveled to California, Seattle, and then Austin and Dallas to photograph our members doing what they love. So we find our members for these photo shoots largely based on who’s sharing on social, so we know that people are already really enthusiastic about the brand and also comfortable in front of a camera, because these folks, they’re not paid models, they are real people with varied interests and in different industries, and we just loved capturing them in their element. Stacy: So to start out with, we have Matt Allison in San Francisco, and then our very own Miz. Matt shot some hoops for us, played tennis for us, and it also happens to be his birthday today. So happy birthday, Matt, if you get to hear this. Miz biked around the Presidio, captured lots of gorgeous shots. It’s exciting to be able to add different types of activities to our content, because we’ve really focused on urban photography in the past, and that has largely meant training and working out in very urban environments. So it was nice to add an element of nature through some of these photos. Next slide. Stacy: These two gals are from Dallas. We have Carly who is a fitness trainer at Trophy, a gym in Dallas, and it was great to capture images of women in gyms. We have a lot of great assets already from BARWIS of pro athletes, mostly men in gyms, and it was great to round out that selection. And then also Mallory, who is… she works for Southwest, but then also has an amazing Instagram. You guys should follow all of the handles that I’ve listed here, but she shares lots of glucose friendly recipes on her Instagram on a consistent basis. Stacy: All right, next slide. Stacy: Got to meet Ben’s friend, Jay, for a photo shoot on the beach. We followed him as he surfed in Pacifica. Then we both enjoyed Chi lattes at the end of it, and both spiked very high from them. After that, met up with Kaya, she is a Peloton enthusiast, but by a day she has been an engineer at well-known companies like Calm and Pinterest, and just recently moved close to us. She’s in Boston now for her masters and MBA at MIT, so really impressive. Stacy: Let’s see. Oops, I keep trying to change. Can you go forward on the next slide? Stacy: Other features always love shooting with Dr. Casey. We love photographing her amazing plant-based recipes. She needs her own cookbook, and a lot of these assets will support a very beautiful rebrand that we have for her Instagram that’s as bright and colorful as her own personality. And then you got to speak with Natalie last week. She’s based out of Seattle and she was on the Friday forum and got to share a little bit. But I love that this picture of her in the Aqua tank top, she encapsulates so many things I love. She has a very sentimental tattoo with a quote that she loves on her shoulder. She loves nature and she loves Levels. So that was some of her feedback from this photo. Stacy: And so last one, I think. Chrissy Chowdry, or Chowdry, was wonderful to work with in Austin. She has a design background, so she knew all of the great spots to shoot. It was really easy, we got tons done in an hour. She is also a founder of a young company called Stagger, and they create tools for content creators to design beautiful things around brands. So I feel like she would say that better than I just did, but it was great working with her. Stacy: And then Will and Steph Hamlin and their adorable pup Clay, back in the Bay Area. Is that it? Is there one more? Nope. Stacy: So just to wrap it up, all of these assets support the different visual elements of Levels brand, and just are an important part of communicating our message. We want to be capturing people when they are feeling happy, and healthy, and strong as a result of being able to manage their glucose. And so, yeah, passing it on to Mike. Josh Clemente: Thank you, Stacy. Mike Haney: Great. Good transition there. The center photo here is actually taken from that most recent photo shoot, I think. I think that’s where I grabbed that one from. So just quickly the articles this week, the thing to call it here is the one in the left and the one in the far right are both partner driven articles. So we had the folks from Inward Breath do this piece about the effect of breath work on metabolic health. And then we had a nice contributor piece from Biosense about Ketone monitoring, and how it can work CGM. So those are both good. Next slide just quickly. Mike Haney: I just wanted to give a brief peek into something we’re spending a lot of time on right now on the content side, which is thinking about how we can take the content that we’re creating, particularly the longer blog posts, but also things like the Insta live interviews and turn those into lots of other pieces. And Casey and I had a really awesome call this week with the team that does this for Dr. Hyman, tons of really good insights. I pasted a couple of slides that… or a couple of Instagram posts from Dr. Hyman there, that kind of show one of the takeaways we got, which is really communicating shareable information and how they think about these different channels. Mike Haney: So lots more to come on this, but this is just kind of a glimpse into something we’re working on for kind of next phase of content. Josh Clemente: Love it. Content’s always my favorite. That breathing exercises piece was phenomenal. I did not expect it to be so tactical, so great work. All right. We’re coming up on the wire here on time. So if anyone has to leave early, we understand, but we’re going to do the 10 second contributions individually. Andrew is not in, so Hal, you’re going to kick us off with 10 seconds personal encourage. Hao Li: All right. To be the first one is super easy. I just want to, thank Dr. Lustig, your books and the presentations enlightened me on my metabolic health awareness. So it’s really appreciated. Dr. Robert Lustig: Thank you. Thank you. Josh Clemente: Awesome, Stacy? Stacy: Plus one to Dr. Lustig, your book is both exciting and scary at the same time. And on the personal side, we got a Peloton in the last couple weeks and I think I’m addicted. So I’m excited about that. Josh Clemente: That’s a common theme, common refrain, Justin. Justin Stanley: I’m excited to maybe add the metabolical book to my reading list, and bring it up in the queue. And I’m also looking forward personally, I’ve been going through the second three-body problem book. It’s great, and I’m going to continue that this weekend. Josh Clemente: Very nice. Lori, if you’re on the call, please jump in. I don’t think she is. Dom. Dominic D’Agostino: Well, it’s great to have Dr. Lustig on the scientific advisory board. I have a couple of his podcast lined up to listen to, and personally, I’m at my parents in New Jersey this week, and it’s great to see them. And the next call will be with Allison Hall, getting an update on the study, which seems to be going very well. Josh Clemente: Awesome. Enjoy the trip, Sam. Sam Corcos: Yeah, I’m going to jump on the bandwagon. I’m very excited to have Dr. Lustig on board, and I appreciate you being the man in the arena. You’ve endured a lot of criticism, and most of it unwarranted, but I really appreciate you pushing through all of that. Josh Clemente: Ditto. I don’t think John is in. John, if you are, correct me. Marilo, over to you. Marillo Nicacio: All right. So easy plus one on Dr. Lustig, I’m a big fan not only of metabolical, but also the Hacking Of The American Mind was also… gave me a lot of insight on the difference between pleasure and the serotonin, and… I’m sorry, I’m nervous I fear a little bit. But anyways, great books, big fan. And also, the product velocity that we keep increasing, and you can see the product really taking shape. Really excited about that. On a personal note, went out for a run on Wednesday, felt some tightness on my foot, so on the next day I picked up yoga which I’m enjoying, quite a bit more than I thought I would. So yeah. Josh Clemente: I can see it, enjoy that. I’m excited to have Dr. Lustig on the call. I get a lot of energy from these calls at the end of the week. It’s a great way to go into the weekend. And specifically today, it’s a jam-packed session, but I’m just feeling the electricity. So thank you for bringing what you bring. Alan. Alan McLean: It’s a big week for work highlights this week. I mean, seeing charts. Dr. Lustig, like your book is one of the reasons I’m here, that was very exciting to have you with us. It just feels like a perfect convergence of all this exciting stuff at the end of the week here. So yeah, I’m very excited about us starting to evaluate scores, and how scores might work. And from a personal side, I’m trying to get fit again. So everything seems brighter when you’re starting to get a little bit fitter. So that’s great. Josh Clemente: Nice. Dr. Lustig. Dr. Robert Lustig: Well, first of all, I’m excited to be with so many like-minded people. There are not that many, they’re relatively few and far between, but you’ve congregated them in one place for me and I appreciate that. The other thing I’m excited about is that, in the last week I’ve done two podcasts that were sort of out of my comfort zone. One was Jeffrey Sacks’ book club, and we basically talked economics. And then the other one, was a podcast call Repast, out of UCLA Resnick Center for food policy and obesity, where we talked about law. Dr. Robert Lustig: And the fact that my work has influenced people outside of the medical sphere, is very energizing. And so I’m excited about that. Josh Clemente: Amazing. I went back and re-listened to your episode with Dr. Ateah on The Drive yesterday, and it was very interesting to hear how all of those patterns wove right into the metabolical. And anyway, one of my favorite shows. Dr. Robert Lustig: Hopefully he’ll cover the book specifically. Josh Clemente: I hope so. Dr. Robert Lustig: He’s supposedly listening to it now. Josh Clemente: I’m sure he is. Can’t wait for his breakdown. Haney. Mike Haney: Yeah. I have to join in and say plus one to Dr. Lustig. When you said, the following of the science, I think that really is as you picked up probably from Casey, the mantra of what we do on everything here, and particularly on the content side. So it’s really a great boost to have your kind of expertise here. Personally, I’m excited this weekend is our big anniversary blowout, post COVID trip to L.A. So we pick up our Model X tomorrow, and off to Bel Air for the weekend. Josh Clemente: Cool. Very nice. Enjoy not having to drive. Mike D. Mike DiDonato: Yeah, obviously plus one Dr. Lustig, thank you so much. Other one, Ben, big shout out. You know, we’ve been working closer and it’s just been awesome, been a lot of fun. As some of you may know, I can be a little intense and I like to go, go, go, go, go. And our energy’s aligned. And then last one, tomorrow three-day weekend, I kind of like to exercise and that means a Mark workout’s coming. So I’m pretty excited to do that. Josh Clemente: I think I’ll be joining. Gabriel, are you on the call? I don’t think so. Mercy Clemente: I was just really, it was exciting to see the photos Stacy updated. Those were really cool and I’m excited to see them on our Instagram and all our social platforms. I think they’re going to do really well. So Stacy, thanks for doing that. And then personally, I actually forgot it was a three day weekend, so I’m excited for that. Josh Clemente: Nice. We’re at time. We’re going to finish these out, but for anyone who has other responsibilities, please feel free to pop off. Miz. Michael Mizrahi: On the personal side, I’m in New York, got to meet Josh, David, Tom JM, I think that was all of us, on Monday which was awesome. So some in person time. Sam, don’t worry, we recorded the dinner, we’re good. No information asymmetry. And then I’m in New York for one more week and then headed back to San Francisco on Tuesday. So looking forward to being back home. David Flinner: Yeah, that was awesome. Ben. Ben Grynol: On the personal side, just on the tail end of metabolic and loving the book. It’s awesome. Josh Clemente: Nice. JM. Josh Mohrer: Yeah, it was really nice seeing some folks in person on Monday. Really nice seeing Dr. Lustig today. Excited for the long weekend. Monday is my birthday. I’m turning 39 starting the 40th year, which I’m very excited for and hope you all have a great weekend. Josh Clemente: Happy early birthday, Jesse. Jesse Lavine: Yeah. Plus one on Dr. Lustig. I’m reading Hacking Of The American Mind right now, and I’m loving it. And on a personal side, my brother and sister are in town and it’s really awesome to be with them. So yeah. Josh Clemente: Very nice. Casey. Casey Means: Yeah. So plus one, thank you for being on the call, Dr. Lustig. Thank you so much as well as. As Josh said, I’m- Dr. Robert Lustig: I’m going to interrupt you, okay? So before everyone leaves, if you ever call me Dr. Lustig again, I will brain you, okay? I am Rob, I am- Casey Means: Rob. Dr. Robert Lustig: … not your doctor. I am- David Flinner: Dr. Lustig. Dr. Robert Lustig: I am not. Casey Means: Guys, we’re on a first name basis now with Rob, this is an exciting day for our whole team. I would just also say I’m really excited about this whole Twitch for metabolism, shareable profile stuff. Thanks for sharing about that, David. And personally, I’m training for another half marathon, I’m just on my first week, I’m following a Hal Higdon program, and I’m really excited to get back into it. I’ve been in a running lull for a few months, so I’m super, super psyched for that one week down. Josh Clemente: Very nice. Exciting. All right. Well, Justin is going to get his story of the week next week. And so with that, killer meeting everyone. Thank you to our special guest, and thanks to everyone watching this, and those of you who have contributed. Have a great weekend, happy Memorial Day, and I’ll see you next week. Dr. Robert Lustig: Pleasure.
May 28, 2021
May 27, 2022